Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz175.560
Abstract: The most common, aggressive malignant brain tumor is Glioblastoma (GBM) with patient median survival of 15–21 months. Patients with GBM face devastation of diagnosis, disease-burden, and hardship of seeking accurate information regarding treatment options. Evolving…
read more here.
Keywords:
patients caregivers;
caregiver;
innv innovative;
educational platforms ... See more keywords